BridgeMD

Sign in

Sarcopenia clinical trials

Explore recruiting sarcopenia clinical trials.

Recruiting sarcopenia studies right now

Study details & eligibility ClinicalTrials.gov record

Study details & eligibility ClinicalTrials.gov record

Study details & eligibility ClinicalTrials.gov record

Study details & eligibility ClinicalTrials.gov record

Study details & eligibility ClinicalTrials.gov record

Study details & eligibility ClinicalTrials.gov record

Study details & eligibility ClinicalTrials.gov record

Study details & eligibility ClinicalTrials.gov record

Study details & eligibility ClinicalTrials.gov record

Study details & eligibility ClinicalTrials.gov record

Study details & eligibility ClinicalTrials.gov record

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Sarcopenia trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

SARA-31: A phase 3 trial to evaluate the efficacy and safety of BIO-101 in elderly patients suffering from severe SARcopeniA: an interventional, randomized double-blind placebo- controlled, clinical trial.

Belgium

Therapeutic confirmatory (Phase III) EU CTIS Study details

Randomized, double-blind, placebo-controlled study evaluating the efficacy and safety of nandrolone decanoate therapy and therapy with complex physiotherapy and diet in the treatment of sarcopenia

Poland

Therapeutic exploratory (Phase II) EU CTIS Study details

PREDICTION OF COMPLICATIONS IN PATIENTS UNDERGOING SURGICAL TREATMENT OF HEPATIC TUMORS

Denmark

Therapeutic use (Phase IV) EU CTIS Study details

A randomized non-comparative phase II study of Maintenance therapy with OSE2101 plus FOLFIRI, or FOLFIRI after induction therapy with FOLFIRINOX in patients with locally advanced or metastatic Pancreatic ductal adenocarcinoma.

France

Therapeutic exploratory (Phase II) EU CTIS Study details

BIOMarkers in Endometrial Cancer - A phase III open label randomized trial to determine the efficacy of biomarker staging as compared to conventional staging in women with presumed early-stage endometrial cancer (The BIOMEC trial)

Sweden

Therapeutic confirmatory (Phase III) EU CTIS Study details

Randomized, double-blind, placebo-controlled study on the efficacy and safety of nicotinamide in patients with liver fibrosis.

Spain

Therapeutic exploratory (Phase II) EU CTIS Study details

Sarcopenia trials by city

Sarcopenia in Toronto Sarcopenia in Vancouver Sarcopenia in Montreal Sarcopenia in Calgary Sarcopenia in Edmonton Sarcopenia in Ottawa Sarcopenia in Winnipeg Sarcopenia in Quebec City Sarcopenia in Hamilton Sarcopenia in Kitchener Sarcopenia in London Sarcopenia in Halifax Sarcopenia in New York Sarcopenia in Los Angeles Sarcopenia in Chicago Sarcopenia in Houston